期刊文献+

高同型半胱氨酸血症及药物干预 被引量:1

下载PDF
导出
摘要 高同型半胱氨酸血症是导致动脉粥样硬化的一个独立危险因子,基因突变及维生素缺乏是其主要病因。近年来对高同型半胱氨酸血症的发病机制及药物干预进行了大量研究。本文将对这两方面的研究进展作一综述。
出处 《国外医学(老年医学分册)》 2005年第1期11-15,共5页 Foreign Medical Sciences(Geriatrics)
基金 福建省科技项目基金(2001Z042)
  • 相关文献

参考文献25

  • 1惠英,吴宜勇,肖路延,唐志毅,吴玉丽,李燕春.绝经后妇女激素补充治疗后同型半胱氨酸及超声心动图改变的初步观察[J].中华妇产科杂志,2002,37(10):598-600. 被引量:7
  • 2Yano H, Nakaso K, Yasui K et al. Mutations of the MTHFR gene (428C > T and [ 458G > T + 459C > T ] )markedly decrease MTHFR enzyme activity. Neurogenetics, 2004; 5 (2): 135-140.
  • 3Tungtrongchitr R, Pongpaew P, Tongboonchoo C et al.Serum homocysteine, B12 and folic acid concentration in Thai overweight and obese subjects. International Journal for Vitamin & Nutrition Research, 2003; 73 (1): 8-14.
  • 4Righetti M, Tommasi A, Lagona C et al. Effective homocysteine- lowering vitamin B treatment in peritoneal dialysis patients. Petit Dial Int, 2004; 24 (4) : 373-377.
  • 5Baro L, Martinez- ferez A, Rodriguez C et al. The administration of a multvitamin/mineral fortified dairy product improves folate status and reduces plasma hornocystein concentration in women of reproductive age. Int J Vitam Nutr Res, 2004; 74 (3): 234-240.
  • 6Hustad S, Ueland PM, Voliset SE,et al. Riboflavin as a determinant of plasma total homocysteine: effect modification by the methyenetetrahydrofolate reductase C677T polymorphism. Clinical Chemistry, 2000; 46: 81065-81071.
  • 7Skoupy S, Fodinger M, Veitl Met al. Riboflavin is a dterminant of total homocysteine plasma concentrations in end- stage renal disease patients. Journal of the American Society of Nephrology, 2002; 13 (5): 1331-1337.
  • 8Dierkes J, Westphal S, Luley C et al. Fenofibrate- induced hyperhomocysteinaemia: clinical implications and management. Drug,Safety, 2003; 26 (2): 81-91.
  • 9Desouza C, Keebler M, Mc Namara DB et al. Drugs affecting homocysteine metabolism: Impact on cardiovascular risk. Drugs, 2002; 64 (4): 605-616.
  • 10Samman S, Sivarajah G, June C et al. A mixed fruit and vegetable concentrate increases plasma antioxidant vitamins and folate and lowers plasma homocysteine in men. J Nutr, 2003; 133:2188-2193.

二级参考文献8

  • 1Mijatovic V,Kenemans P,Netelenbos C,et al.Postmenopausal oral 17beta-estradiol continuously combined with dydrogesterone reduces fasting serum homobcysteine levels[].Fertility and Sterility.1998
  • 2Sheyr J,Malthora A,Schaible TF,et al.Effects of gonadectomy and hormonal replacement on rat hearts[].Circulation Research.1987
  • 3Pines A,Fisman EZ,Levo Y,et al.The effects of hormone replacement therapy in normal postmenopausal women: measurements of Dopplerderived parameters of aortic flow[].American Journal of Obstetrics and Gynecology.1991
  • 4Voutilainen S,Hippelainen M,Hulkko S,et al.Left ventricular diastolic function by doppler echocardiography in relation to hormonal replacement therapy in healthy postmenopausal women[].The American Journal of Cardiology.1993
  • 5Aarsand AK,Carlsen SM.Folate administration reduces circulating homocysteine levels in NIDDM patients on long-term metformin treatment[].Journal of Internal Medicine.1998
  • 6van der Mooren MJ,Wouters MGAJ,Blom HJ.Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women[].European Journal of Clinical Investigation.1994
  • 7Mijatovic V,Kenemans P,Netelenbos C,et al.A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women[].Obstetrics and Gynecology.1998
  • 8van Baal WM,Smolders RG,van der Mooren MJ,et al.Hormone replacement therapy and plasma homocysteine levels[].Obstetrics and Gynecology.1999

共引文献6

同被引文献5

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部